JP Morgan Chase
PROK icon

JP Morgan Chase’s ProKidney PROK Stock Holding History

JP Morgan Chase’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88.2K Buy
54,108
+21,983
+68% +$37.1K ﹤0.01% 6291
2026
Q2 		$60.7K Buy
32,125
+31,369
+4,149% +$57.4K ﹤0.01% 6349
2026
Q1 		$1.22K Hold
756
– – ﹤0.01% 7095
2025
Q4 		$1.69K Hold
756
– – ﹤0.01% 6968
2025
Q3 		$1.83K Sell
756
-1,667,886
-100% -$4.44M ﹤0.01% 6932
2025
Q2 		$988K Buy
1,668,642
+1,615,243
+3,025% +$1.26M ﹤0.01% 4387
2025
Q1 		$46.8K Sell
53,399
-13,016
-20% -$18.1K ﹤0.01% 5905
2024
Q4 		$112K Buy
66,415
+19,585
+42% +$35.3K ﹤0.01% 5709
2024
Q3 		$89.9K Buy
46,830
+18,472
+65% +$41.9K ﹤0.01% 5744
2024
Q2 		$69.8K Buy
28,358
+7,546
+36% +$20.3K ﹤0.01% 5712
2024
Q1 		$34.1K Sell
20,812
-9,252
-31% -$13.6K ﹤0.01% 6075
2023
Q4 		$53.5K Buy
30,064
+133
+0.4% +$285 ﹤0.01% 5976
2023
Q3 		$137K Sell
29,931
-18,076
-38% -$173K ﹤0.01% 5298
2023
Q2 		$537K Buy
48,007
+43,725
+1,021% +$465K ﹤0.01% 4440
2023
Q1 		$49K Buy
4,282
+915
+27% +$9.7K ﹤0.01% 5708
2022
Q4 		$23K Buy
+3,367
New +$32.2K ﹤0.01% 5844
2022
Q3 		– Sell
-100,000
Closed -$995K – 6769
2022
Q2 		$995K Sell
100,000
-310,356
-76% -$3.07M ﹤0.01% 4082
2022
Q1 		$4.06M Buy
+410,356
New +$4.05M ﹤0.01% 3181
2021
Q4 		– Sell
-150,000
Closed -$1.47M – 6895
2021
Q3 		$1.47M Buy
150,000
+55,300
+58% +$544K ﹤0.01% 4021
2021
Q2 		$959K Buy
+94,700
New +$957K ﹤0.01% 4325

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Brown University
Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

JP Morgan Chase's PROK Position: Q3 2026 in Review

JP Morgan Chase increased its ProKidney (PROK) stake by 68% in Q3 2026, buying an estimated $37.1K and bringing the position to 54,108 shares worth $88.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6291.

JP Morgan Chase first reported a position in PROK in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.06M in Q1 2022. 67 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • JP Morgan Chase held 54,108 shares of ProKidney worth $88.2K as of Q3 2026.
  • JP Morgan Chase bought 21,983 ProKidney shares in Q3 2026, an estimated $37.1K.
  • ProKidney made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6291 holding.
  • JP Morgan Chase first reported a position in ProKidney in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's ProKidney position peaked at $4.06M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.